REGENTIS BIOMATERIALS LTD.(RGNT) - 2025 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Commission File No.: 001-42834 Regentis Biomaterials Ltd. (Exact name of registrant as specified in its charter) Translation of registrant's name into English: Not applicable State of Israel (Jurisdiction of incorporation or organization) (Address of principal executive of ices) Dr. Ehud Geller Chief Executive Officer 60 Medinat Hayehudim 4676652, Israel ehud@regentis.co.il FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR ( ...